{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T21:16:46Z","timestamp":1773955006043,"version":"3.50.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2861,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK39588"],"award-info":[{"award-number":["DK39588"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK037003"],"award-info":[{"award-number":["DK037003"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institutes of Health\/National Institute of Diabetes and Digestive and Kidney Diseases","award":["DK058369"],"award-info":[{"award-number":["DK058369"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>In our previous work, including analysis of more than 10,000 sera from control patients and patients with a variety of liver diseases, we have demonstrated that with the use of recombinant autoantigens, antimitochondrial autoantibodies (AMAs) are only found in primary biliary cirrhosis (PBC) and that a positive AMA is virtually pathognomonic of either PBC or future development of PBC. Although the mechanisms leading to the generation of AMA are enigmatic, we have postulated that xenobiotic-induced and\/or oxidative modification of mitochondrial autoantigens is a critical step leading to loss of tolerance. This thesis suggests that a severe liver oxidant injury would lead to AMA production. We analyzed 217 serum samples from 69 patients with acute liver failure (ALF) collected up to 24 months post-ALF, compared with controls, for titer and reactivity with the E2 subunits of pyruvate dehydrogenase, branched chain 2-oxo-acid dehydrogenase, and 2-oxo-glutarate dehydrogenase. AMAs were detected in 28\/69 (40.6%) ALF patients with reactivity found against all of the major mitochondrial autoantigens. In addition, and as further controls, sera were analyzed for autoantibodies to gp210, Sp100, centromere, chromatin, soluble liver antigen, tissue transglutaminase, and deaminated gliadin peptides; the most frequently detected nonmitochondrial autoantibody was against tissue transglutaminase (57.1% of ALF patients).<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>\n                                 <jats:bold>The strikingly high frequency of AMAs in ALF supports the thesis that oxidative stress-induced liver damage may lead to AMA induction. The rapid disappearance of AMAs in these patients provides further support for the contention that PBC pathogenesis requires additional factors, including genetic susceptibility.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.21828","type":"journal-article","created":{"date-parts":[[2007,7,26]],"date-time":"2007-07-26T22:46:54Z","timestamp":1185490014000},"page":"1436-1442","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":107,"title":["Antimitochondrial antibodies in acute liver failure: Implications for primary biliary cirrhosis"],"prefix":"10.1097","volume":"46","author":[{"given":"Patrick S. C.","family":"Leung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Rossaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ogyi","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Miyakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary L.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric M.","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"Suppl 5","key":"R1-17-20241201","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1289\/ehp.99107s5667","article-title":"Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions.","volume":"107","author":"Powell","year":"1999","journal-title":"Environ Health Perspect"},{"key":"R2-17-20241201","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-2005-916324","article-title":"Etiology of primary biliary cirrhosis: the search for the culprit.","volume":"25","author":"Leung","year":"2005","journal-title":"Semin Liver Dis"},{"key":"R3-17-20241201","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaut.2007.02.003","article-title":"The X and why of xenobiotics in primary biliary cirrhosis.","volume":"28","author":"Rieger","year":"2007","journal-title":"J Autoimmun"},{"key":"R4-17-20241201","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.4049\/jimmunol.174.9.5874","article-title":"Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2octynoic acid.","volume":"174","author":"Amano","year":"2005","journal-title":"J Immunol"},{"key":"R5-17-20241201","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.4049\/jimmunol.172.10.6444","article-title":"Xenobioticinduced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible.","volume":"172","author":"Amano","year":"2004","journal-title":"J Immunol"},{"key":"R6-17-20241201","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2006.06.002","article-title":"Identification of 2nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis.","volume":"27","author":"Rieger","year":"2006","journal-title":"J Autoimmun"},{"key":"R7-17-20241201","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.4049\/jimmunol.170.10.5326","article-title":"Immunization with a xenobiotic 6bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies.","volume":"170","author":"Leung","year":"2003","journal-title":"J Immunol"},{"key":"R8-17-20241201","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJM199312163292508","article-title":"Acute liver failure.","volume":"329","author":"Lee","year":"1993","journal-title":"N Engl J Med"},{"key":"R9-17-20241201","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-2003-42641","article-title":"Acute liver failure in the United States.","volume":"23","author":"Lee","year":"2003","journal-title":"Semin Liver Dis"},{"key":"R10-17-20241201","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/0006-2952(93)90201-7","article-title":"Oxidative stress in cultured hepatocytes exposed to acetaminophen.","volume":"45","author":"Adamson","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"R11-17-20241201","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0891-5849(95)00023-Q","article-title":"Oxidative stress by acute acetaminophen administration in mouse liver.","volume":"19","author":"Lores Arnaiz","year":"1995","journal-title":"Free Radic Biol Med"},{"key":"R12-17-20241201","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1172\/JCI200110716","article-title":"Bcl2dependent oxidation of pyruvate dehydrogenaseE2, a primary biliary cirrhosis autoantigen, during apoptosis.","volume":"108","author":"Odin","year":"2001","journal-title":"J Clin Invest"},{"key":"R13-17-20241201","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/hep.20491","article-title":"Sidechain biology and the immunogenicity of PDCE2, the major autoantigen of primary biliary cirrhosis.","volume":"40","author":"Mao","year":"2004","journal-title":"Hepatology"},{"key":"R14-17-20241201","first-page":"1018","article-title":"Myeloperoxidasepositive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxidemediated reactions.","volume":"38","author":"Wu","year":"2003","journal-title":"Hepatology"},{"key":"R15-17-20241201","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2006.04.005","article-title":"IL2 receptor alpha deficiency and features of primary biliary cirrhosis.","volume":"27","author":"Aoki","year":"2006","journal-title":"J Autoimmun"},{"key":"R16-17-20241201","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interviewbased study of 1032 patients.","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"R17-17-20241201","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.510240117","article-title":"Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.","volume":"24","author":"Moteki","year":"1996","journal-title":"Hepatology"},{"key":"R18-17-20241201","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/hep.1840150302","article-title":"Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis.","volume":"15","author":"Leung","year":"1992","journal-title":"Hepatology"},{"key":"R19-17-20241201","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.4049\/jimmunol.161.10.5157","article-title":"Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis.","volume":"161","author":"Migliaccio","year":"1998","journal-title":"J Immunol"},{"key":"R20-17-20241201","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/0091-6749(94)90156-2","article-title":"Cloning, expression, and primary structure of Metapenaeus ensis tropomyosin, the major heatstable shrimp allergen.","volume":"94","author":"Leung","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"R21-17-20241201","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.510270303","article-title":"Characterization of antimitochondrial antibodies in health adults.","volume":"27","author":"Mattalia","year":"1998","journal-title":"Hepatology"},{"key":"R22-17-20241201","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"3rd, Therneau TM, Homburger HA, Batts KP, et al. Epidemiology and natural history of primary biliary cirrhosis in a US community.","volume":"119","author":"Kim","year":"2000","journal-title":"Gastroenterology"},{"key":"R23-17-20241201","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaut.2006.11.004","article-title":"T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis.","volume":"27","author":"Allina","year":"2006","journal-title":"J Autoimmun"},{"key":"R24-17-20241201","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/jhep.2001.26514","article-title":"Detection of antimitochondrial autoantibodies in immunofluorescent AMAnegative patients with primary biliary cirrhosis using recombinant autoantigens.","volume":"34","author":"Miyakawa","year":"2001","journal-title":"Hepatology"},{"key":"R25-17-20241201","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.21583","article-title":"A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMAnegative primary biliary cirrhosis.","volume":"45","author":"Oertelt","year":"2007","journal-title":"Hepatology"},{"key":"R26-17-20241201","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1568-9972(01)00020-9","article-title":"Antimitochondrial antibodies in primary biliary cirrhosis: the role of xenobiotics.","volume":"1","author":"Long","year":"2002","journal-title":"Autoimmun Rev"},{"key":"R27-17-20241201","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.4049\/jimmunol.144.9.3367","article-title":"Structural requirement for autoreactivity on human pyruvate dehydrogenaseE2, the major autoantigen of primary biliary cirrhosis. Implication for a conformational autoepitope.","volume":"144","author":"Surh","year":"1990","journal-title":"J Immunol"},{"key":"R28-17-20241201","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/lt.500050102","article-title":"Etiology and outcome for 295 patients with acute liver failure in the United States.","volume":"5","author":"Schiodt","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"R29-17-20241201","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1053\/jhep.2001.24267","article-title":"Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminopheninduced acute liver failure in the mouse.","volume":"33","author":"Ferret","year":"2001","journal-title":"Hepatology"},{"key":"R30-17-20241201","first-page":"371","article-title":"Primary biliary cirrhosis: further biochemical and immunological characterization of mitochondrial antigens.","volume":"62","author":"MendelHartvig","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"R31-17-20241201","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hep.20300","article-title":"Acetaminophen misconceptions.","volume":"40","author":"Rumack","year":"2004","journal-title":"Hepatology"},{"key":"R32-17-20241201","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0891-5849(01)00743-2","article-title":"CYP2E1dependent toxicity and oxidative stress in HepG2 cells.","volume":"31","author":"Cederbaum","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"R33-17-20241201","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/01.ALC.0000108654.77178.03","article-title":"Abnormal hepatic methionine and glutathione metabolism in patients with alcoholic hepatitis.","volume":"28","author":"Lee","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"R34-17-20241201","first-page":"657","article-title":"CYP2E1biochemical and toxicological aspects and role in alcoholinduced liver injury.","volume":"73","author":"Cederbaum","year":"2006","journal-title":"Mt Sinai J Med"},{"key":"R35-17-20241201","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1053\/j.gastro.2006.12.036","article-title":"Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.","volume":"132","author":"Colmenero","year":"2007","journal-title":"Gastroenterology"},{"key":"R37-17-20241201","first-page":"1001","article-title":"Increased heme oxygenase1 and decreased deltaaminolevulinate synthase expression in the liver of patients with acute liver failure.","volume":"14","author":"Fujii","year":"2004","journal-title":"Int J Mol Med"},{"key":"R38-17-20241201","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1034\/j.1600-0528.2002.017402.x","article-title":"Primary biliary cirrhosis: an orchestrated immune response against epithelial cells.","volume":"174","author":"Gershwin","year":"2000","journal-title":"Immunol Rev"},{"key":"R39-17-20241201","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.20051911","article-title":"NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis.","volume":"203","author":"Irie","year":"2006","journal-title":"J Exp Med"},{"key":"R40-17-20241201","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.4049\/jimmunol.177.3.1655","article-title":"Antimitochondrial antibodies and primary biliary cirrhosis in TGFbeta receptor II dominantnegative mice.","volume":"177","author":"Oertelt","year":"2006","journal-title":"J Immunol"},{"key":"R41-17-20241201","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/hep.21385","article-title":"IL2 receptor alpha() mice and the development of primary biliary cirrhosis.","volume":"44","author":"Wakabayashi","year":"2006","journal-title":"Hepatology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.21828","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200711000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T13:09:52Z","timestamp":1733058592000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200711000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.21828","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}